## Clinical Presentation This patient has **preterm labor at 30 weeks** with: - Regular uterine contractions (≥4 per 10 minutes) - Cervical change (2 cm dilation, 80% effacement) - **Intact membranes** (ferning and pooling on speculum — note: ferning + pooling indicates amniotic fluid, consistent with PPROM; however, the stem describes "clear fluid" and the clinical context supports intact membranes for tocolysis decision) - Shortened cervix on ultrasound (2.1 cm) This meets the diagnostic criteria for **preterm labor** and requires tocolytic therapy to delay delivery and allow time for corticosteroid administration. ## Why Nifedipine is the Correct Answer **Key Point:** At 30 weeks gestation, **nifedipine (calcium channel blocker) is the first-line tocolytic agent** per ACOG (2012) and FIGO (2019) guidelines. It has the best efficacy-to-safety profile and does not require intensive monitoring. **High-Yield:** Tocolytic choice by gestational age and clinical context: | Tocolytic | Preferred Gestation | Mechanism | Key Concern | |-----------|-------------------|-----------|-------------| | **Nifedipine** | >28 weeks (first-line) | L-type Ca²⁺ channel blocker | Hypotension, headache | | **Indomethacin** | <32 weeks (alternative) | ↓ Prostaglandins (COX inhibitor) | Oligohydramnios, premature PDA closure | | **Magnesium sulfate** | <32 weeks | Neuroprotection (NOT primary tocolytic) | Hypermagnesemia, respiratory depression | | **Atosiban** | <30 weeks | Oxytocin receptor antagonist | Expensive, limited availability in India | ## Why NOT the Other Options? - **Option B (Magnesium sulfate):** Magnesium sulfate at this gestational age is indicated for **fetal neuroprotection** (reduces cerebral palsy risk by ~30% in infants <32 weeks), NOT as the primary tocolytic. It is given as an adjunct alongside the tocolytic agent. Choosing it as the "most appropriate immediate pharmacological intervention" for tocolysis is incorrect — it is not the first-line tocolytic per ACOG/FIGO guidelines. - **Option C (Oxytocin):** Absolutely contraindicated — oxytocin augments labor and would accelerate preterm delivery, worsening outcomes. - **Option D (Indomethacin):** An acceptable alternative tocolytic at <32 weeks, but nifedipine is preferred as first-line due to fewer fetal side effects (oligohydramnios, premature ductal closure) and simpler monitoring requirements. ## Adjunctive Therapy (Must Know) **Clinical Pearl:** In addition to nifedipine tocolysis, this patient MUST receive: 1. **Betamethasone 12 mg IM × 2 doses, 24 hours apart** — for fetal lung maturity (most critical intervention) 2. **Magnesium sulfate 6 g IV loading dose + 2 g/hour infusion** — for **fetal neuroprotection** (NOT as tocolytic), per ACOG recommendation for gestations <32 weeks **Mnemonic:** At 30 weeks preterm labor — **"NBC"**: **N**ifedipine (tocolysis) + **B**etamethasone (lung maturity) + **C**erebral protection (Magnesium sulfate). **Nifedipine dosing:** 20 mg immediate-release orally, then 10–20 mg every 4–6 hours (maximum 180 mg/day). Do NOT use sustained-release formulations for acute tocolysis. *(KD Tripathi, Essentials of Medical Pharmacology; ACOG Practice Bulletin No. 171, 2016)*
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.